Understanding Impact of Trade Agreements Act (TAA) Compliant Pharmaceutical Products

IndustryPharmaceutical Manufacturer
ProblemA generic pharmaceutical manufacturer contacted PHSI to evaluate their competitors’ compliance with the Trade Agreements Act (TAA). TAA compliance fosters fair and open international trade and requires that the United States government prioritize TAA compliant products. The client desired a review of their competitors’ products to determine the TAA compliance to make strategic decisions about their own products.
PHSI SolutionPHSI researched the client requested products to identify the country of manufacturing. The TAA compliance of that country was classified for each product. PHSI provided the client with comprehensive report detailing each drug, the number of TAA compliant and non-compliant competitors, and listed the manufacturers and countries in each group.
ResultsThe generic manufacturer gained the timely TAA compliance status for their competitors’ products. The client’s knowledge of competitor TAA compliance was a key resource to make strategic decisions on specific products regarding their own manufacturing location and compliance with TAA.